ESYT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.192000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.850200E-01
Normal-vs-Stage2
3.312200E-01
Normal-vs-Stage3
5.442300E-02
Normal-vs-Stage4
1.742220E-01
Stage1-vs-Stage2
6.968400E-01
Stage1-vs-Stage3
2.595200E-01
Stage1-vs-Stage4
8.779000E-01
Stage2-vs-Stage3
1.040800E-01
Stage2-vs-Stage4
2.855400E-01
Stage3-vs-Stage4
7.006000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.619800E-01
Normal-vs-AfricanAmerican
3.666600E-01
Normal-vs-Asian
1.058810E-01
Caucasian-vs-AfricanAmerican
9.906400E-01
Caucasian-vs-Asian
1.267170E-01
AfricanAmerican-vs-Asian
2.093000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.528800E-01
Normal-vs-Female
3.169800E-01
Male-vs-Female
2.914800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.748400E-01
Normal-vs-Age(41-60Yrs)
8.459800E-01
Normal-vs-Age(61-80Yrs)
4.192000E-01
Normal-vs-Age(81-100Yrs)
5.493800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.359600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.047030E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.782400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.509650E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.521650E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.359200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.672300E-02
Normal-vs-Daily Drinker
2.219400E-01
Normal-vs-Weekly Drinker
1.362380E-01
Normal-vs-Occasional Drinker
9.634400E-01
Normal-vs-Social Drinker
4.549000E-01
Non Drinker-vs-Daily Drinker
4.414600E-01
Non Drinker-vs-Weekly Drinker
8.759800E-01
Non Drinker-vs-Occasional Drinker
2.966300E-02
Non Drinker-vs-Social Drinker
2.781600E-01
Daily Drinker-vs-Weekly Drinker
6.289200E-01
Daily Drinker-vs-Occasional Drinker
9.013900E-02
Daily Drinker-vs-Social Drinker
6.709200E-01
Weekly Drinker-vs-Occasional Drinker
5.274300E-02
Weekly Drinker-vs-Social Drinker
4.484200E-01
Occasional Drinker-vs-Social Drinker
2.417800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.984600E-01
Normal-vs-Grade 2
1.713020E-01
Normal-vs-Grade 3
6.571400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.938000E-01
Grade 1-vs-Grade 3
2.583600E-01
Grade 1-vs-Grade 4
3.984600E-01
Grade 2-vs-Grade 3
7.931800E-01
Grade 2-vs-Grade 4
1.713020E-01
Grade 3-vs-Grade 4
6.571400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.607800E-01
Normal-vs-NonDiabetic
5.101800E-01
Diabetic-vs-NonDiabetic
8.949600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.953800E-01
Normal-vs-NoPancreatitis
5.313200E-01
Pancreatitis-vs-NoPancreatitis
8.125800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.307200E-01
Normal-vs-N1
3.408400E-01
N0-vs-N1
5.846600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.335800E-01
Normal-vs-TP53-NonMutant
9.252400E-02
TP53-Mutant-vs-TP53-NonMutant
8.139600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
